Beruflich Dokumente
Kultur Dokumente
leading biotech firm in the industry. This company was among the firsts to deliver
recombinant DNA. But, like any other biotech firm, the keys to success were finding
new drugs through research and then having the drugs approved by the Food and
Drug Administration (FDA). This approval process required extensive trials that
would take a massive amount of time and can cost hundreds of millions of dollars to
the firm. Therefore, MoGen needed to have a consistent supply of cash to fund R&D
and to maintain financial flexibility for future challenges and opportunities. This is
where the company turned to previous business partner, Merrill Lynch, to assist in
raising the needed funds. MoGen had worked with Merrill Lynch in the past and had
previously raised $10 billion for the company. MoGen estimated that they would
need roughly $10 billion in capital for the fiscal year of 2006. Approximately $5 billion
had been generated internally which they had on hand, while the other $5 billion
would need to be raised externally. Dan Maanavi, the managing director of Merrill
debt offering by MoGen, Inc. The proceeds from the convertible debt offering were to
be allotted for the funding of research and development (R&D) expenses, working
much funding needs Merrill Lynch and MoGen had to decide on how to price such a
significant and important financing. The $5 billion offering represented the largest
such single offering in history, therefore, it is critical the pricing be set at a level that
generates sufficient demand without giving away too much. Thus, the problem was
to find the right combination of coupon rate and conversion premium that would be
The first alternative for MoGen is to have a convertible debt offering with 15%
conversion premium and a coupon rate of 1.17% (Appendix 2). This alternative has
pros and cons for both the issuing company and the investors. The pro for MoGen
would be the low coupon rate, which would mean a smaller coupon payment, and
less money paid out. The con for MoGen would be the very low conversion premium.
Management may think they are sending a bad signal to the market with such a low
potential of stock. Now, the pros for the investors in this alternative are that it is a
very low conversion premium. Investors want the lowest conversion premium so they
can have a better chance of reaching it. The con of this alternative is that it is a low
The second alternative for MoGen is to have a convertible debt offering with 20%
conversion premium and a coupon rate of 1.56% (Appendix 3). This alternative has
pros and cons for both the issuing company and the investors. The pro for MoGen
would be a still pretty low coupon rate. This coupon rate isnt as low as the first
alternative but this option has a higher conversion premium, which would entice even
more investors. The con for MoGen is not a very high conversion premium. Issuing
their stock is already selling at a depressed price, which represents an excellent buy
for investors. Now, the pro for investors is once again the lower conversion premium.
Most convertible debt offerings have a conversion premium between 10%-40%. This
is still relatively low compared to that range. The con for investors is still a lower
coupon rate. Investors want higher coupon rates to make more money.
The third alternative for MoGen is to have a convertible debt offering with 25%
conversion premium and a coupon rate of 1.95% (Appendix 4). This alternative has
pros and cons for both the issuing company and the investors. The pro for Investors
is a coupon rate much lower than the year-to-maturity (YTM) yield, which is at
5.75%. Maanavi, knows the convertible should carry a coupon rate much lower than
the 5.75% and this alternative accomplishes. The con for MoGen is the conversion
premium is not as high as it could be. The management will still believe they can
have a higher conversion premium with how the stock is selling right now. Now, the
pro for the investors is the conversion premium. It is still well below the 40% it could
be which makes it a good investment. The con for investors is they will always want
The fourth alternative for MoGen is to have a convertible debt offering with 30%
conversion premium and a coupon rate of 2.34% (Appendix 5). This alternative has
pros and cons for both the issuing company and the investors. The pro for MoGen is
the fact that conversion premium is higher than the average of normal convertible
debt offerings. They are usually between 10%-40%, which would make the average
be 25%. This alternative is higher than that average making the management happy
with this conversion premium. This can also be a con for MoGen though because the
conversion premium is higher than the previous alternatives and that this may make
the demand decline. With this offering being worth $5 billion, MoGen has to make
sure the demand will be high enough to where investors will want to buy and they
can make the full amount. Now, the pro for investors is the higher coupon rate
compared to previous alternatives. This higher coupon rate will help increase their
investment if it reaches the conversion premium. But, the con is that the conversion
premium is higher than average convertibles and it will be harder to reach it.
The last alternative for MoGen is to have a convertible debt offering with 35%
conversion premium and a coupon rate of 2.73% (Appendix 6). This alternative has
pros and cons for both the issuing company and the investors. The pro for MoGen is
the high conversion premium. With a conversion premium this high it will be much
less likely for the stock to reach it making it a better offering for MoGen. The con is
that with a conversion premium closer to the ceiling of most offerings it makes the
demand shrink and will make it more difficult to reach the $5 billion needed. The pro
for the investors is the higher coupon rate. Having the largest coupon rate of all the
Investors may believe the higher conversion premium is worth the risk and make
more money. The con for investors is the highest conversion premium of all
alternatives. The chances of reaching this conversion premium is much lower than
any other alternative, which could scare away many of the investors, they want.
Fundamental investors dont like to invest in anything 40% or higher and at 35% this
Recommendation:
Based on the alternatives analyzed I believe the best alternative is the 30%
conversion premium with a 2.34% coupon rate. The previous convertible offering
MoGen had was in 2003 when the stock price was $61 and the conversion price was
$90. By looking at appendix 1, I calculated the conversion premium for this offering
was 47.5% and the coupon rate was 2.9%. This gave me a good basis on what
would work for MoGen in this convertible debt offering. I knew that convertible debt
offerings carried conversion premiums in the range of 10%-40%. In 2003, they had
an offering of 47.5%, which made me realize they could have a higher conversion
premium and still get the demanded needed. Now, this was a much larger offering at
$5 billion and I knew it should be lower if they were going to make sure that demand
was met. But, I knew it could be higher than the average based on how well the
stock was doing and managements feelings based on the stock price. Therefore, I
believe 30% conversion premium would still generate demand and be able to show
investors management has confidence in the upside potential of the stock. Next, the
decision to have the coupon rate at 2.34% was based on equaling the face value of
$1,000 per bond. With a 30% conversion premium, to equal the face value the
coupon rate would have to be 2.34%. This coupon rate would work well because for
the previous convertible debt offering in 2003 the coupon rate was higher and it still
never reached the conversion premium. In addition, MoGen stock price had a five-
year appreciation from 2001 to 2005 of 12.2%. If this trend continued for the next 5
years of this bond then the conversion price would have to be $87.49, which is much
less than the conversion price for this offering. The conversion price for this
alternative is $101.37, which is much less than $87.49. Therefore, the chances of
reaching the conversion premium are very small. In conclusion, those are the
reasons why I believe alternative 5 would be the best choice for MoGen Inc.